Success Metrics

Clinical Success Rate
72.7%

Based on 8 completed trials

Completion Rate
73%(8/11)
Active Trials
0(0%)
Results Posted
113%(9 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_2
7
64%
Ph phase_1
4
36%

Phase Distribution

4

Early Stage

7

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
7(63.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(8)
Terminated(3)

Detailed Status

Completed8
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
72.7%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (36.4%)
Phase 27 (63.6%)

Trials by Status

terminated327%
completed873%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_1

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

NCT01433289
completedphase_2

Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer

NCT00088946
terminatedphase_2

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

NCT01060345
completedphase_2

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

NCT00596011
completedphase_2

Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis

NCT00718094
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT01433289Phase 1

Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals

Completed
NCT00088946Phase 2

Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer

Completed
NCT01060345Phase 2

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

Terminated
NCT00596011Phase 2

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

Completed
NCT00718094Phase 2

Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis

Completed
NCT00676793Phase 2

A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression

Completed
NCT00707252Phase 1

Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer

Terminated
NCT01451723Phase 2

Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II

Terminated
NCT00363805Phase 2

Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease

Completed
NCT00836719Phase 1

Safety of Polyphenon E in Multiple Sclerosis Pilot Study

Completed
NCT00262743Phase 1

Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11